Transactions
70
Insider / CYTOKINETICS INC
Malik Fady Ibraham
EVP Research & Development at CYTOKINETICS INC
- Company
- CYTOKINETICS INC
- Ticker
- CYTK
- First filing on record
- October 7, 2025
- Latest trade on record
- October 20, 2026
- SEC filings
- EDGAR ↗
Malik Fady Ibraham, EVP Research & Development at CYTOKINETICS INC, has disclosed 70 transactions in CYTK since October 7, 2025: 0 purchases (0 open-market buys) and 25 sales, worth about $5.8M at the reported prices. The latest was filed October 20, 2026, 0 days after the trade; 3 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
25
Avg. disclosure lag
0.7d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Malik Fady Ibraham made no purchases and 23 sales worth $5.0M, plus 41 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Malik Fady Ibraham has traded 1 stock on record; the largest by dollars is CYTK.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 24 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 40 | 119,000 | $503K |
| S | Open-market sale | 23 | 74,440 | $5.1M |
| A | Grant or award | 5 | 72,498 | — |
| F | Shares withheld for tax | 2 | 3,074 | $198K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 48 | 0 | 17 · $4.3M |
| 2025 | 22 | 0 | 8 · $999K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| CYTK | Option / conversion M | October 20, 2026 | October 20, 2026 | 0d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | October 20, 2026 | October 20, 2026 | 0d | 3,500 | $64 | $224K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | October 20, 2026 | October 20, 2026 | 0d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | October 6, 2026 | October 6, 2026 | 0d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | October 6, 2026 | October 6, 2026 | 0d | 3,500 | $61 | $215K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | October 6, 2026 | October 6, 2026 | 0d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | September 22, 2026 | September 22, 2026 | 0d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | September 22, 2026 | September 22, 2026 | 0d | 3,500 | $68 | $239K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | September 22, 2026 | September 22, 2026 | 0d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | September 8, 2026 | September 8, 2026 | 0d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | September 8, 2026 | September 8, 2026 | 0d | 3,500 | $75 | $264K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | September 8, 2026 | September 8, 2026 | 0d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | August 18, 2026 | August 18, 2026 | 0d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | August 18, 2026 | August 18, 2026 | 0d | 3,500 | $76 | $265K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | August 18, 2026 | August 18, 2026 | 0d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | July 21, 2026 | July 23, 2026 | 2d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | July 21, 2026 | July 23, 2026 | 2d | 3,500 | $81 | $282K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | July 21, 2026 | July 23, 2026 | 2d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | July 7, 2026 | July 7, 2026 | 0d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | July 7, 2026 | July 7, 2026 | 0d | 3,500 | $87 | $303K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | July 7, 2026 | July 7, 2026 | 0d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | June 23, 2026 | June 23, 2026 | 0d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | June 23, 2026 | June 23, 2026 | 0d | 3,500 | $80 | $278K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | June 23, 2026 | June 23, 2026 | 0d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | June 9, 2026 | June 9, 2026 | 0d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | June 9, 2026 | June 9, 2026 | 0d | 3,500 | $68 | $238K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | June 9, 2026 | June 9, 2026 | 0d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | May 19, 2026 | May 20, 2026 | 1d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | May 19, 2026 | May 20, 2026 | 1d | 3,500 | $76 | $265K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | May 19, 2026 | May 20, 2026 | 1d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | May 5, 2026 | May 5, 2026 | 0d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | May 5, 2026 | May 5, 2026 | 0d | 3,500 | $77 | $271K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | May 5, 2026 | May 5, 2026 | 0d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | April 21, 2026 | April 21, 2026 | 0d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | April 21, 2026 | April 21, 2026 | 0d | 3,500 | $66 | $230K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | April 21, 2026 | April 21, 2026 | 0d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | April 7, 2026 | April 8, 2026 | 1d | 1,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Option / conversion M | April 7, 2026 | April 8, 2026 | 1d | 3,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | April 7, 2026 | April 8, 2026 | 1d | 1,000 | $65 | $65K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | April 7, 2026 | April 8, 2026 | 1d | 1,000 | $11 | $11K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | April 7, 2026 | April 8, 2026 | 1d | 3,500 | $65 | $228K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | April 7, 2026 | April 8, 2026 | 1d | 3,500 | $8 | $27K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell S | March 17, 2026 | March 18, 2026 | 1d | 4,397 | $62 | $273K | Form 4 ↗ | ||
| CYTK | Sell S | March 17, 2026 | March 18, 2026 | 1d | 7,636 | $62 | $475K | Form 4 ↗ | ||
| CYTK | Other A | March 15, 2026 | March 17, 2026 | 2d | 39,527 | — | — | derivative | Form 4 ↗ | |
| CYTK | Other A | March 15, 2026 | March 17, 2026 | 2d | 1,665 | — | — | derivative | Form 4 ↗ | |
| CYTK | Other A | March 15, 2026 | March 17, 2026 | 2d | 27,306 | — | — | Form 4 ↗ | ||
| CYTK | Sell S | March 9, 2026 | March 10, 2026 | 1d | 2,907 | $61 | $177K | Form 4 ↗ | ||
| CYTK | Sell F | December 22, 2025 | December 29, 2025 | 7d | 1,016 | $63 | $64K | late | Form 4 ↗ | |
| CYTK | Other A | December 22, 2025 | December 29, 2025 | 7d | 2,000 | — | — | late | Form 4 ↗ | |
| CYTK | Other A | December 22, 2025 | December 29, 2025 | 7d | 2,000 | — | — | late | Form 4 ↗ | |
| CYTK | Option / conversion M | December 16, 2025 | December 16, 2025 | 0d | 2,200 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | December 16, 2025 | December 16, 2025 | 0d | 2,200 | $61 | $135K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | December 16, 2025 | December 16, 2025 | 0d | 2,200 | $11 | $23K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Sell F | December 3, 2025 | December 5, 2025 | 2d | 2,058 | $65 | $134K | Form 4 ↗ | ||
| CYTK | Option / conversion M | December 2, 2025 | December 2, 2025 | 0d | 2,200 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | December 2, 2025 | December 2, 2025 | 0d | 2,200 | $64 | $141K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | December 2, 2025 | December 2, 2025 | 0d | 2,200 | $11 | $23K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | November 18, 2025 | November 18, 2025 | 0d | 2,200 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | November 18, 2025 | November 18, 2025 | 0d | 2,200 | $66 | $146K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | November 18, 2025 | November 18, 2025 | 0d | 2,200 | $11 | $23K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | November 4, 2025 | November 4, 2025 | 0d | 2,295 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | November 4, 2025 | November 4, 2025 | 0d | 2,295 | $60 | $137K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | November 4, 2025 | November 4, 2025 | 0d | 2,295 | $11 | $24K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | October 21, 2025 | October 21, 2025 | 0d | 2,105 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | October 21, 2025 | October 21, 2025 | 0d | 2,105 | $58 | $123K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | October 21, 2025 | October 21, 2025 | 0d | 2,105 | $11 | $22K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | October 7, 2025 | October 7, 2025 | 0d | 2,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| CYTK | Sell S | October 7, 2025 | October 7, 2025 | 0d | 2,000 | $61 | $121K | 10b5-1 plan | Form 4 ↗ | |
| CYTK | Option / conversion M | October 7, 2025 | October 7, 2025 | 0d | 2,000 | $11 | $21K | 10b5-1 plan | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 20, 2026 | Form 4 | 0001061983-26-000100 | 3 | published | EDGAR ↗ |
| October 6, 2026 | Form 4 | 0001061983-26-000098 | 3 | published | EDGAR ↗ |
| September 22, 2026 | Form 4 | 0001061983-26-000096 | 3 | published | EDGAR ↗ |
| September 8, 2026 | Form 4 | 0001061983-26-000092 | 3 | published | EDGAR ↗ |
| August 18, 2026 | Form 4 | 0001061983-26-000088 | 3 | published | EDGAR ↗ |
| July 23, 2026 | Form 4 | 0001061983-26-000084 | 3 | published | EDGAR ↗ |
| July 7, 2026 | Form 4 | 0001061983-26-000075 | 3 | published | EDGAR ↗ |
| June 23, 2026 | Form 4 | 0001061983-26-000069 | 3 | published | EDGAR ↗ |
| June 9, 2026 | Form 4 | 0001061983-26-000067 | 3 | published | EDGAR ↗ |
| May 20, 2026 | Form 4 | 0001061983-26-000053 | 3 | published | EDGAR ↗ |
| May 5, 2026 | Form 4 | 0001061983-26-000051 | 3 | published | EDGAR ↗ |
| April 21, 2026 | Form 4 | 0001061983-26-000043 | 3 | published | EDGAR ↗ |
| April 8, 2026 | Form 4 | 0001061983-26-000034 | 6 | published | EDGAR ↗ |
| March 18, 2026 | Form 4 | 0001061983-26-000027 | 2 | published | EDGAR ↗ |
| March 17, 2026 | Form 4 | 0001061983-26-000020 | 3 | published | EDGAR ↗ |
| March 10, 2026 | Form 4 | 0001061983-26-000017 | 1 | published | EDGAR ↗ |
| December 29, 2025 | Form 4 | 0001061983-25-000055 | 3 | published | EDGAR ↗ |
| December 16, 2025 | Form 4 | 0001061983-25-000050 | 3 | published | EDGAR ↗ |
| December 5, 2025 | Form 4 | 0001061983-25-000044 | 1 | published | EDGAR ↗ |
| December 2, 2025 | Form 4 | 0001061983-25-000041 | 3 | published | EDGAR ↗ |
| November 18, 2025 | Form 4 | 0001061983-25-000037 | 3 | published | EDGAR ↗ |
| November 4, 2025 | Form 4 | 0001061983-25-000029 | 3 | published | EDGAR ↗ |
| October 21, 2025 | Form 4 | 0001061983-25-000025 | 3 | published | EDGAR ↗ |
| October 7, 2025 | Form 4 | 0001061983-25-000009 | 3 | published | EDGAR ↗ |
Other insiders at CYTOKINETICS INC
- Callos Andrew EVP, Chief Commercial Officer 71 rows
- Blum Robert I President & CEO 52 rows
- Lee Sung EVP, Chief Financial Officer 38 rows
- Kaye Edward M. MD Director 17 rows
- WIERENGA WENDELL Director 16 rows
- HENDERSON JOHN T Director 13 rows
- Daly James M Director 8 rows
- Harrington Robert Arthur Director 8 rows
- Wysenski Nancy Director 7 rows
- PARSHALL B LYNNE Director 6 rows
Everyone on file, with contracts and lobbying under the company's name: CYTOKINETICS INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 24 | 70 | October 7, 2025 | October 20, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.